Skip to main content

Personalised Pancreatic Cancer Vaccination Therapy derived from Autologous Tumor Cells and Neoantigens

Project description

Innovative vaccine against pancreatic cancer

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Coordinator

CYTUVAX BV
Net EU contribution
€ 50 000,00
Address
Oxfordlaan 55
6229 EV Maastricht
Netherlands

See on map

Region
Limburg (NL) Zuid-Limburg
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 21 429,00